Geode Capital Management, LLC Verona Pharma PLC Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 62,741 shares of VRNA stock, worth $4.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,741

Previous 62,081 1.06%

Holding current value

$4.03 Million

Previous $1.79 Million 63.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$28.71 - $47.02 $18,948 - $31,033	660 Added 1.06%	62,741 $2.91 Million
Q3 2024 Nov 12, 2024	SELL	$15.46 - $30.16 $59,721 - $116,508	-3,863 Reduced 5.86%	62,081 $1.79 Million
Q2 2024 Aug 09, 2024	BUY	$11.48 - $17.02 $6,566 - $9,735	572 Added 0.87%	65,944 $953,000
Q1 2024 May 13, 2024	BUY	$15.3 - $20.24 $65,162 - $86,202	4,259 Added 6.97%	65,372 $1.05 Million
Q4 2023 Feb 13, 2024	BUY	$11.94 - $20.47 $102,970 - $176,533	8,624 Added 16.43%	61,113 $1.21 Million
Q3 2023 Nov 13, 2023	BUY	$16.3 - $22.09 $122,201 - $165,608	7,497 Added 16.66%	52,489 $855,000
Q2 2023 Aug 11, 2023	BUY	$19.41 - $23.43 $236,840 - $285,892	12,202 Added 37.21%	44,992 $951,000
Q1 2023 May 15, 2023	BUY	$18.06 - $25.27 $20,516 - $28,706	1,136 Added 3.59%	32,790 $658,000
Q4 2022 Feb 13, 2023	SELL	$9.84 - $26.13 $105,248 - $279,486	-10,696 Reduced 25.26%	31,654 $827,000
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $115,559 - $379,337	27,913 Added 193.34%	42,350 $432,000
Q1 2022 May 13, 2022	BUY	$4.82 - $6.98 $5,610 - $8,124	1,164 Added 8.77%	14,437 $72,000
Q4 2021 Feb 11, 2022	BUY	$3.91 - $7.08 $10,033 - $18,167	2,566 Added 23.97%	13,273 $89,000
Q3 2021 Nov 12, 2021	BUY	$5.29 - $6.35 $56,640 - $67,989	10,707 New	10,707 $58,000

Others Institutions Holding VRNA

# of Institutions

215

Shares Held

70.3M

Call Options Held

1.4M

Put Options Held

299K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $3.91B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Verona Pharma PLC Transaction History